Share
HOTLINE: call us at +49 30 65499 145 | Not all products are available in the USA.
Expanding the dimension of blood purification Working to save lives together.
New Blog Post

Targeted Use of CytoSorb® in Septic Shock Linked to Reduced Mortality and Vasopressor Need – New Meta-Analysis

Read more
New Event

May 16 | 73rd ESCVS Symposium: Hemoadsorption by CytoSorb in Cardiac Surgery – New data and latest experiences, 13:00-13:30 EET

Link to Congress
CytoSorbents & Hemoadsorption

When it comes to critical health challenges, count on us.

We understand that healthcare professionals need to be able to rely on technology that protects patients.

 

CytoSorbents’ powerful adsorption technology is expanding the dimensions of blood purification, with one of the fastest ways to restore balance and control damage – beyond what dialysis can do.

Our Innovation

The incomparable power of bead technology

Our solutions are based on our proprietary biocompatible, highly porous polymer bead technology, which works to effectively, safely, and selectively remove excessive levels of potentially harmful substances.

Our Team of Experts

Expertise you can count on the moment you need it.

Our Support

CytoSorbents in over 75 countries worldwide.

CytoSorbents

Voices around the world

world map
Critical Care
Prof. Olfa Hamzaoui
Reims, France

Prof. Hamzaoui shares a compelling summary of key highlights, clinical insights, and the growing role of CytoSorb Therapy in critical care.

Cardiovascular
Dr. Serdar Gunaydin
Ankara, Turkey

One of the most important indications for us to use CytoSorb® in is cardiac surgery, as it has also been cited in many guidelines.

Critical Care
Dr. Voyka Gorjup
Ljubljana, Slovenia

The most prominent clinical effect is the lowering of vasopressors, hemodynamic stability, lowering of interleukins and in those patients who are on vvECMO…